Radio Free never takes money from corporate interests, which ensures our publications are in the interest of people, not profits. Radio Free provides free and open-source tools and resources for anyone to use to help better inform their communities. Learn more and get involved at radiofree.org

Biogen’s outrageous original price for Aduhelm, $56,000 per year, is the poster child for how dysfunctional our drug pricing system has become and it is the perfect example of why Medicare should be negotiating drug prices with the pharmaceutical industry. If the administration takes no action, Medicare recipients will continue to see their biggest premium More

The post On Medicare Limiting Coverage for Alzheimer’s Drug appeared first on CounterPunch.org.


This content originally appeared on CounterPunch.org and was authored by Sen. Bernard Sanders.

Citations

[1] On Medicare Limiting Coverage for Alzheimer’s Drug - CounterPunch.org ➤ https://www.counterpunch.org/2022/01/12/on-medicare-limiting-coverage-for-alzheimers-drug/[2] On Medicare Limiting Coverage for Alzheimer’s Drug - CounterPunch.org ➤ https://www.counterpunch.org/2022/01/12/on-medicare-limiting-coverage-for-alzheimers-drug/[3] Home - CounterPunch.org ➤ https://www.counterpunch.org/